;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Histogenics amends IPO

    Histogenics Corp., Waltham, Mass. Business: Musculoskeletal Date announced: 2014-11-14 Type: IPO To be raised: Up to $64.3 million Shares: 4.3 million Price: $13-$15 Underwriters: Cowen; Needham; Canaccord; BTIG …

    Published on 11/17/2014
  • Kane amends private placement of units

    Kane Biotech Inc. (TSX-V:KNE), Winnipeg, Manitoba Business: Drug delivery, Dermatology Date announced: 2014-11-10 Type: Private placement of units To be raised: Up to C$1.2 million ($1.1 million) Units: 24 million Price…

    Published on 11/17/2014
  • Neothetics amends IPO

    Neothetics Inc., San Diego, Calif. Business: Ophthalmic, Endocrine/Metabolic Date announced: 2014-11-10 Type: IPO To be raised: Up to $64.5 million Shares: 4.3 million Price: $13-$15 Underwriters: Piper Jaffray; …

    Published on 11/17/2014
  • S1 Biopharma amends IPO

    S1 Biopharma Inc., New York, N.Y. Business: Genitourinary Date announced: 2014-11-10 Type: IPO To be raised: Up to $44.3 million Shares: 2.8 million Price: $12-$14 Underwriters: MLV; Northland Securities Inc. …

    Published on 11/17/2014
  • BeiGene completes venture financing

    BeiGene Co. Ltd., Beijing, China Business: Cancer Date completed: 2014-11-14 Type: Venture financing Raised: RMB450 million ($73.5 million) Investors: Strategic investors; angel investors; CITIC Capital Partners; …

    Published on 11/17/2014
  • Blueprint Medicines completes venture financing

    Blueprint Medicines, Cambridge, Mass. Business: Cancer Date completed: 2014-11-12 Type: Venture financing Raised: $50 million Investors: Partner Fund Management; Wellington Management; RA Capital Management; Tavistock …

    Published on 11/17/2014
  • Capnia completes IPO

    Capnia Inc. (NASDAQ:CAPN), Redwood City, Calif. Business: Diagnostic Date completed: 2014-11-13 Type: IPO Raised: $10.7 million Shares: 1.7 million Price: $6.50 (unit) Shares after offering: 6.5 million Underwriters: …

    Published on 11/17/2014
  • Cellectis completes warrant exercise

    Cellectis S.A. (Euronext:ALCLS), Paris, France Business: Gene/Cell therapy, Genomics Date completed: 2014-11-12 Type: Warrant exercise Raised: EUR13.2 million ($16.5 million) Shares: 1.5 million Shares after offering: …

    Published on 11/17/2014
  • Coronado Biosciences completes private placement

    Coronado Biosciences Inc. (NASDAQ:CNDO), Burlington, Mass. Business: Autoimmune, Cancer Date completed: 2014-11-07 Type: Private placement Raised: $3.5 million Shares: 2.2 million Price: $1.61 Shares after offering: 46.…

    Published on 11/17/2014
  • Critical Outcome Technologies completes private placement of units

    Critical Outcome Technologies Inc. (TSX-V:COT; OTCQB:COTQF), London, Ontario Business: Cancer, Autoimmune, Infectious Date completed: 2014-11-07 Type: Private placement of units Raised: $1.2 million Units: 5.1 million …

    Published on 11/17/2014
  • FibroGen completes IPO

    FibroGen Inc. (NASDAQ:FGEN), San Francisco, Calif. Business: Hematology, Renal, Pulmonary Date completed: 2014-11-14 Type: IPO Raised: $145.8 million Shares: 8.1 million Price: $18 Shares after offering: 56.7 million …

    Published on 11/17/2014
  • Genmab completes warrant exercise

    Genmab A/S (CSE:GEN; OTCBB:GMXAY), Copenhagen, Denmark Business: Antibodies, Cancer, Autoimmune Date completed: 2014-11-12 Type: Warrant exercise Raised: DKK20.2 million ($3.4 million) Shares: 146,148 Shares after …

    Published on 11/17/2014
  • Gilead completes private placement of senior convertible notes

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Biopharmaceuticals, Infectious, Pulmonary Date completed: 2014-11-13 Type: Private placement of senior convertible notes Raised: $4 billion Shares …

    Published on 11/17/2014
  • Glionova completes venture financing

    Glionova Therapeutics, Stockholm, Sweden Business: Cancer Date completed: 2014-11-12 Type: Venture financing Raised: SEK42 million ($5.7 million) Investors: Novo Seeds; HealthCap

    Published on 11/17/2014
  • GTx completes private placement of units

    GTx Inc. (NASDAQ:GTXI), Memphis, Tenn. Business: Cancer, Musculoskeletal Date completed: 2014-11-10 Type: Private placement of units Raised: $43.4 million Units: 64.3 million Price: $0.68 (unit) Shares after offering: …

    Published on 11/17/2014
  • Helomics completes venture financing

    Helomics Corp., Pittsburgh, Pa. Business: Diagnostic, Pharmacogenetics, Bioinformatics Date completed: 2014-11-12 Type: Venture financing Raised: $60 million Investor: Healthcare Royalty Partners Note: The company …

    Published on 11/17/2014
  • Histide completes venture financing

    Histide AG, Schindellegi, Switzerland Business: Gene/Cell therapy Date completed: 2014-11-10 Type: Venture financing Raised: CHF4.5 million ($4.7 million) Investors: Parter Capital Group; private investors

    Published on 11/17/2014
  • Isis Pharmaceuticals completes private placement of senior convertible notes

    Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Business: Cancer, Endocrine/Metabolic, Cardiovascular Date completed: 2014-11-12 Type: Private placement of senior convertible notes Raised: $425 million Shares …

    Published on 11/17/2014
  • NeuroDerm completes IPO

    NeuroDerm Ltd. (NASDAQ:NDRM), Ness Ziona, Israel Business: Neurology, Drug delivery Date completed: 2014-11-14 Type: IPO Raised: $45 million Shares: 4.5 million Price: $10 Shares after offering: 17 million Underwriters:…

    Published on 11/17/2014
  • PRA Health Sciences completes IPO

    PRA Health Sciences Inc. (NASDAQ:PRAH), Raleigh, N.C. Business: Supply/Service Date completed: 2014-11-13 Type: IPO Raised: $305.6 million Shares: 17 million Price: $18.00 Shares after offering: 57.3 million …

    Published on 11/17/2014
  • Ziarco completes venture financing

    Ziarco Group Ltd., Canterbury, U.K. Business: Inflammation, Dermatology, Autoimmune Date completed: 2014-11-10 Type: Venture financing Raised: $33.1 million Investors: New Enterprise Associates; Lundbeckfond Ventures; …

    Published on 11/17/2014
  • Coherus BioSciences financial update

    Coherus BioSciences Inc. (NASDAQ:CHRS), Redwood City, Calif. Business: Biosimilars Date announced: 2014-11-13 Note: Coherus raised $6.8 million through the sale of 507,402 shares at $13.50 to cover the overallotment …

    Published on 11/17/2014
  • CymaBay financial update

    CymaBay Therapeutics Inc. (NASDAQ:CBAY), Newark, Calif. Business: Endocrine/Metabolic Date announced: 2014-11-07 Note: CymaBay filed a shelf registration covering the sale of up to $100 million of its securities. The …

    Published on 11/17/2014
  • Dyadic International financial update

    Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla. Business: Genomics, Supply/Service, Biomanufacturing Date announced: 2014-10-30 Note: Dyadic extended to Jan. 1, 2016 the maturity date of $6.7 million in 2010 and …

    Published on 11/17/2014
  • Dynavax financial update

    Dynavax Technologies Corp. (NASDAQ:DVAX), Berkeley, Calif. Business: Inflammation, Infectious, Autoimmune Date announced: 2014-11-07 Note: Dynavax implemented a 1-for-10 reverse stock split. Following the split, Dynavax…

    Published on 11/17/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993